Adam Hansard - 14 Dec 2021 Form 4/A - Amendment Insider Report for Applied Therapeutics Inc. (APLT)

Role
Chief Commercial Officer
Signature
/s/ Shoshana Shendelman as attorney-in-fact
Issuer symbol
APLT
Transactions as of
14 Dec 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
11 Jan 2022, 17:41:40 UTC
Date Of Original Report
16 Dec 2021
Previous filing
28 May 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Award $0 +31,700 +94% $0.000000 65,270 14 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on December 14, 2022, and one-twelfth (1/12th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each quarter thereafter, subject to the Reporting Person continuing to provide services through each such date.

Remarks:

This amendment is being filed solely to correct the vesting schedule for the compensatory Restricted Stock Units reported on the Reporting Person's Form 4 filed on December 16, 2021.